Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.05 |
mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.27 | 0.05 |
mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.05 |
mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.063 | 0.05 |
mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.28 | 0.05 |
mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.055 | 0.05 |